FDA expands blood pressure drug recall

THIS MORNING A RECALL FOR BLOOD PRESSURE DRUGS HAS BEEN EXPANDED— TORRENT PHARMACEUTICAL S SAYS TWO OF ITS BLOOD PRESSURE MEDICATIONS WERE FOUND TO HAVE TRACE AMOUNTS OF A POTENTIALLY CANCER-CAUSING IMPURITY. THE VOLUNTARY RECALL AFFECTS LOW-SAR-TIN LOSARTAN POTASSIUM TABLETS U-P AND LOSARTAN POTASSIUM- HYDRO-CHLORO-THIA-ZIDE TABLETS. THIS RECALL IS RELATED TO THE VAL-SAR-TIN VALSARTAN RECALL THAT HAS BEEN EXPANDED MULTIPLE TIMES SINCE JULY— THAT’S WHEN SEPARATE LOTS OF BLOOD PRESSURE MEDICATIONS FROM DIFFERENT COMPANIES WERE PULLED FROM PHARMACY SHELVES. THE MEDICATIONS ALL CONTAINED EITHER VALSARTAN, LOSARTAN OR IRBESARTAN AND HAD TRACES OF THESE IMPURITIES THAT POSE A CANCER RISK TO USERS. ABORTION CLINICS IN TENNESSEE ARE HOPING TO DEFEAT THE STATES 48 HOUR WAITING PERIOD.

2 comments

  1. I called my pharmacist at Publix Supermarket they said call the doctor. I called the doctor they said call the pharmacist. Just a big run around nobody knows what's going on

Leave a Reply

(*) Required, Your email will not be published